Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.20 $16.47 Friday, 10th May 2024 VRDN stock ended at $13.90. This is 0.0719% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 5.32% from a day low at $13.34 to a day high of $14.05.
90 days $12.20 $21.42
52 weeks $10.93 $28.35

Historical Viridian Therapeutics, Inc. prices

Date Open High Low Close Volume
Jan 24, 2024 $19.17 $19.17 $18.30 $18.78 776 403
Jan 23, 2024 $20.39 $20.51 $18.62 $18.94 968 034
Jan 22, 2024 $20.04 $20.38 $19.54 $20.00 1 125 442
Jan 19, 2024 $20.27 $20.56 $19.82 $20.09 1 444 999
Jan 18, 2024 $21.51 $21.51 $19.48 $20.14 2 867 386
Jan 17, 2024 $21.74 $22.69 $21.23 $22.31 568 927
Jan 16, 2024 $21.87 $22.29 $21.59 $22.11 361 063
Jan 12, 2024 $23.17 $23.69 $22.04 $22.14 798 607
Jan 11, 2024 $23.48 $23.65 $22.60 $22.81 848 862
Jan 10, 2024 $23.56 $24.08 $23.37 $23.82 1 560 427
Jan 09, 2024 $22.48 $24.18 $22.45 $23.70 1 693 606
Jan 08, 2024 $21.05 $23.11 $20.66 $22.87 813 153
Jan 05, 2024 $21.66 $22.41 $20.86 $21.22 506 846
Jan 04, 2024 $21.55 $22.31 $21.18 $22.00 611 708
Jan 03, 2024 $21.97 $22.05 $21.25 $21.51 498 768
Jan 02, 2024 $21.46 $22.98 $21.17 $22.35 897 197
Dec 29, 2023 $22.28 $22.60 $21.43 $21.78 933 262
Dec 28, 2023 $22.55 $22.99 $21.97 $22.39 864 436
Dec 27, 2023 $22.70 $23.51 $22.16 $22.50 998 679
Dec 26, 2023 $22.95 $23.26 $22.31 $22.49 628 599
Dec 22, 2023 $21.90 $22.74 $21.71 $22.46 969 054
Dec 21, 2023 $21.02 $21.48 $20.97 $21.37 548 554
Dec 20, 2023 $22.10 $22.37 $20.38 $20.43 1 034 898
Dec 19, 2023 $21.50 $22.55 $21.47 $22.23 1 108 349
Dec 18, 2023 $19.42 $21.55 $19.00 $21.05 1 848 296
Click to get the best stock tips daily for free!

About Viridian Therapeutics, Inc.

Viridian Therapeutics. Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as ... VRDN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT